Steris (STE) stock: key figures, P/E, revenue and dividend
Health Care · Health Care Equipment · Ireland · ISIN USG8473T1000
Steris financials
| Fiscal year | 2025 | 2026 |
|---|---|---|
| Revenue | 5.46 bn USD | 5.94 bn USD |
| Gross profit | 2.40 bn USD | 2.63 bn USD |
| Operating income | 866.64 m USD | 1.10 bn USD |
| EBIT | 886.99 m USD | 1.11 bn USD |
| Net income | 614.64 m USD | 782.30 m USD |
| Diluted EPS – continuing operations | 6.20 USD | 7.93 USD |
Full history since 2016, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Steris
STERIS plc provides infection prevention products and services in the United States, Ireland, and internationally. It operates through three segments: Healthcare, Applied Sterilization Technologies, and Life Sciences. The company offers cleaning chemistries and sterility assurance products, automated endoscope reprocessing system and tracking products, endoscopy accessories, instruments, washers, and sterilizers and other pieces of capital equipment, as well as equipment used directly in the procedure rooms, including surgical tables, lights, equipment management services, and connectivity solutions; and various preventive maintenance programs, repair services, custom process improvement consulting, and outsourced instrument sterile processing, as well as instrument, devices, and endoscope repair and maintenance services. It also provides process controls and monitoring systems, as well as integrated sterilization equipment, such as accelerators, product handling, and automation; and sterilization modalities, product development, materials testing, and process validation, as well as support services for sterilization equipment and control systems comprising installation, preventive maintenance, updates, repairs, and troubleshooting. In addition, the company offers pharmaceutical detergents, cleanroom disinfectants and sterilants, pharmaceutical grade and research sterilizers and washers, sterility assurance and maintenance products, vaporized hydrogen peroxide room decontamination systems and sterilizers, and high purity water and pure steam generators; and preventive maintenance programs and repair services to support the operation of capital equipment. It serves healthcare providers, medical device and pharmaceutical manufacturers, biopharmaceutical manufacturing facilities, and hospitals. The company was formerly known as New STERIS Limited and changed its name to STERIS plc in November 2015. STERIS plc was founded in 1985 and is headquartered in Mentor, Ohio.
More stocks
- Brown & Brown (BRO)
- CK Infrastructure Holdings Ltd (1038.HK)
- Chocoladefabriken Lindt & Spruengli AG Part (LISP.SW)
- BOE Tech Group (200725.SZ)
- China Merchants Securities Co Ltd (600999.SS)
- Snam SpA (SRG.MI)
- Smurfit Westrock (SW)
- Biontech SE (BNTX)
- Global Payments (GPN)
- Edison International (EIX)
- INSMED Inc (INSM)
- Terumo Corp (4543.T)
Not investment advice. All data without warranty, price as of 14.10.2026. Details in the risk notice.